Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $45.2B | $57.0B | $61.4B | $62.5B | $61.6B | $58.8B | $60.8B | $61.5B | $71.1B | $73.9B | $79.2B | $85.0B | $90.0B | $92.1B | $104.2B | $121.9B | $138.6B | $156.6B | $171.3B | $177.0B |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Elevance Health Inc.'s last 12-month Revenue is $176.8B, based on the financial report for Dec 31, 2024 (Q4 2024).
Over the last year, Elevance Health Inc.'s Revenue growth was 3.2%. The average annual Revenue growth rates for Elevance Health Inc. have been 11.0% over the past three years, 11.2% over the past five years.
Over the last year, Elevance Health Inc.'s Revenue growth was 3.2%, which is higher than industry growth of 0.1%. It indicates that Elevance Health Inc.'s Revenue growth is Good.